XenoPort Inc (XNPT)

7.07
0.05 0.71
Prev Close 7.02
Open 7.04
Day Low/High 7.02 / 7.07
52 Wk Low/High 3.35 / 7.86
Volume 2.62M
Avg Volume 1.64M
Exchange
Shares Outstanding 63.53M
Market Cap 449.13M
EPS -1.30
Div & Yield N.A. (N.A)

Latest News

Arbor Pharmaceuticals And XenoPort Announce The Expiration Of The HSR Act Waiting Period

Arbor Pharmaceuticals And XenoPort Announce The Expiration Of The HSR Act Waiting Period

Arbor Pharmaceuticals, LLC ("Arbor") and XenoPort, Inc. ("XenoPort") (NASDAQ:XNPT) announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, relating to...

Ardelyx Has Big Potential

This small-cap company's shares are half where they ended 2015.

Biotech M&A Waking Up After Long Nap

The uptick in the small- and mid-cap space bodes well for future capital appreciation.

XENOPORT SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Xenoport, Inc. (XNPT) Over The Proposed Sale Of The Company To Arbor Pharmaceuticals, LLC

XENOPORT SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Xenoport, Inc. (XNPT) Over The Proposed Sale Of The Company To Arbor Pharmaceuticals, LLC

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Xenoport, Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of XenoPort, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of XenoPort, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Xenoport's Cost-Cutting Tactics Lead to Buyout With Hefty Premium

Xenoport's Cost-Cutting Tactics Lead to Buyout With Hefty Premium

The biotechnology company, which makes alcoholism drug Horizant, was acquired by privately held Arbor Pharmaceuticals for $467 million in cash, a price lower than at least one analyst expected.

Here's Why XenoPort (XNPT) Stock is Continuing to Surge Today

Here's Why XenoPort (XNPT) Stock is Continuing to Surge Today

XenoPort (XNPT) shares are soaring Monday as Arbor Pharmaceuticals agreed to acquire the company in a deal valued at about $467 million.

XENOPORT, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Believe The Acquisition By Arbor Pharmaceuticals, LLC May Be Unfair To Shareholders

XENOPORT, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Believe The Acquisition By Arbor Pharmaceuticals, LLC May Be Unfair To Shareholders

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of XenoPort, Inc.

Trending Tickers: XNPT, OLED, MON, TPUB

Monsanto rises and Tribune Publishing sinks on separate merger bids.

XenoPort (XNPT) Stock Skyrockets, Arbor Pharmaceuticals Acquiring For $467 Million

XenoPort (XNPT) Stock Skyrockets, Arbor Pharmaceuticals Acquiring For $467 Million

XenoPort (XNPT) shares are soaring Monday on the announcement that Arbor Pharmaceuticals will buy the biopharmaceutical company in a deal valued at about$467 million.

Arbor Pharmaceuticals To Acquire XenoPort

Arbor Pharmaceuticals To Acquire XenoPort

Arbor Pharmaceuticals, LLC (Arbor) and XenoPort, Inc. (XenoPort) (NASDAQ:XNPT) announced today that they have signed a definitive agreement under which Arbor will acquire XenoPort for $7.

XenoPort Reports First Quarter Financial Results

XenoPort Reports First Quarter Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2016.

XenoPort To Release First Quarter Financial Results On May 5, 2016

XenoPort To Release First Quarter Financial Results On May 5, 2016

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 5, 2016 at approximately 4:30 p.

Dr. Reddy's Laboratories And XenoPort Enter Into A U.S. Licensing Agreement For XP23829

Dr. Reddy's Laboratories And XenoPort Enter Into A U.S. Licensing Agreement For XP23829

Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and XenoPort, Inc.

Dr. Reddy's Laboratories And XenoPort Enter Into A U.S. Licensing Agreement For XP23829

Dr. Reddy's Laboratories And XenoPort Enter Into A U.S. Licensing Agreement For XP23829

Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and XenoPort, Inc.

#StopMakingExcuses Awareness Campaign For Restless Legs Syndrome Launches During Sleep Awareness Week 2016

#StopMakingExcuses Awareness Campaign For Restless Legs Syndrome Launches During Sleep Awareness Week 2016

Nearly 7 million Americans suffer from restless legs syndrome (RLS).

XenoPort To Present At The Cowen And Company 36th Annual Health Care Conference

XenoPort To Present At The Cowen And Company 36th Annual Health Care Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2016 Cowen and Company 36th Annual Health Care Conference.

XenoPort Reports Fourth Quarter And Year-End 2015 Financial Results

XenoPort Reports Fourth Quarter And Year-End 2015 Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2015.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

XenoPort To Release Fourth Quarter And Year-End Financial Results On February 25, 2016

XenoPort To Release Fourth Quarter And Year-End Financial Results On February 25, 2016

XenoPort, Inc. (NASDAQ:XNPT) announced today that it will release its fourth quarter and year-end financial results on February 25, 2016 at approximately 4:30 p.